Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COLLAGEN CONTIGEN PHYSICIAN SURVEY: ONLY 23% OF TRAINED UROLOGISTS

This article was originally published in The Gray Sheet

Executive Summary

COLLAGEN CONTIGEN PHYSICIAN SURVEY: ONLY 23% OF TRAINED UROLOGISTS have used the injectable implant for treatment of intrinsic sphincter deficiency, Chief Financial Officer David Foster told investors at a June 22 Piper Jaffray conference in Minneapolis. Conducted in March through May, the survey polled 457 physicians, including 133 trained in November in use of the urinary incontinence device, and 324 untrained. Of the trained physicians who have not yet used the device, 95% plan to use it, the survey found.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002486

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel